IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, “IPIAD- an augmentation regimen added to standard treatment of pancreatic ductal adenocarcinoma using already-marketed repurposed drugs irbesartan, pyrimethamine, itraconazole, azithromycin, and dapsone.”

Researchers explore link between tooth loss and denture usage, diet changes and cognitive decline

A recent npj Aging study assessed the specific brain regions that are impacted by tooth loss and the associated causes.

March 25, 2024

Do You Believe in These Medical Superstitions?

While the medical field usually attracts people who value evidence and facts, even healthcare professionals can be susceptible to superstitions. Not everybody believes superstitions, but

December 28, 2023

Oral Challenge Alone May Be Enough to Rule Out Penicillin Allergy

A direct oral penicillin challenge sufficed to remove an incorrect penicillin allergy label on people considered to have a low-risk history, the international PALACE trial

July 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.